Infection of Vascular Prostheses: A Comprehensive Review-Reference-Cited by-同舟云学术

Infection of Vascular Prostheses: A Comprehensive Review

Published:2023-02-02 Issue:1 Volume:5 Page:148-166
ISSN:2673-1592
Container-title:Prosthesis
language:en
Short-container-title:Prosthesis

Author:

Costa Davide¹²^ORCID,Andreucci Michele³^ORCID,Ielapi Nicola⁴^ORCID,Serraino Giuseppe Filiberto⁵^ORCID,Mastroroberto Pasquale⁵^ORCID,Bracale Umberto Marcello⁶^ORCID,Serra Raffaele²⁷^ORCID

Affiliation:

1. Department of Law, Economics, and Sociology, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

2. Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

3. Department of Health Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

4. Department of Public Health and Infectious Disease, “Sapienza” University of Rome, 00185 Rome, Italy

5. Department of Experimental and Clinical Medicine, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

6. Department of Public Health, University of Naples “Federico II”, 80138 Naples, Italy

7. Department of Medical and Surgical Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

Abstract

Vascular graft or endograft infection (VGEI) is a complex disease that complicates vascular-surgery and endovascular-surgery procedures and determines high morbidity and mortality. This review article provides the most updated general evidence on the pathogenesis, prevention, diagnosis, and treatment of VGEI. Several microorganisms are involved in VGEI development, but the most frequent one, responsible for over 75% of infections, is Staphylococcus aureus. Specific clinical, surgical, radiologic, and laboratory criteria are pivotal for the diagnosis of VGEI. Surgery and antimicrobial therapy are cornerstones in treatment for most patients with VGEI. For patients unfit for surgery, alternative treatment is available to improve the clinical course of VGEI.

Publisher

MDPI AG

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.mdpi.com/2673-1592/5/1/12/pdf

Reference164 articles.

1. Walpoth, B., Bergmeister, H., Bowlin, G., Kong, D., Rotmans, J., and Zilla, P. (2020). Tissue-Engineered Vascular Grafts, Springer. Reference Series in Biomedical Engineering.

2. Evaluation and performance standards for arterial prostheses;Abbott;J. Vasc. Surg.,1993

3. Recent advancements in the bioprinting of vascular grafts;Fazal;Biofabrication,2021

4. Bioengineered vascular grafts: Can we make them off-the-shelf?;Dahl;Trends Cardiovasc. Med.,2011

5. Advancing tissue-engineered vascular grafts via their endothelialization and mechanical conditioning;Antonyshyn;J. Cardiovasc. Surg.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Experience of the Neo-Aortoiliac System (NAIS) Procedure: A Case Series with Review of the Literature;Annals of Vascular Surgery;2024-12

2. Radiotracers for in situ infection imaging: Experimental considerations for in vitro microbial uptake of gallium-68-labeled siderophores;Diagnostic Microbiology and Infectious Disease;2024-09

3. Aortic Endograft Infections: A Race against Time;Complications;2024-06-21

4. Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years;Enfermedades infecciosas y microbiologia clinica (English ed.);2024-05

5. Dalbavancina como tratamiento antibiótico de consolidación en endocarditis infecciosa, infección de dispositivos de estimulación cardiaca y bacteriemia: experiencia clínica de 7 años;Enfermedades Infecciosas y Microbiología Clínica;2024-03